Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARCTURUS THERAPEUTICS HLDGS
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 1,100 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $6,743 as of 2025-Q4. This is a new position.
Current Value
$6,743
Current Shares
1,100
Total Value Change
-$5M
Total Shares Change
-204,452
Other major holders of ARCT: CAPITAL FUND MANAGEMENT S.A., BNP PARIBAS FINANCIAL MARKETS, BANQUE PICTET & CIE SA
New |
| 1,100 |
- |
| $6,743 |
| 0.0% |
| $6.19 |
24 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $13.33 | 0 |
| 2025-Q1 | Decreased | 47,452 | -9.1% | $502,517 | 0.0% | $11.58 | 0 |
| 2024-Q4 | Decreased | 52,189 | -74.6% | $885,648 | 0.0% | $16.58 | 0 |
| 2024-Q3 | Increased | 205,756 | +0.1% | $4.8M | 0.0% | $22.03 | 27 |
| 2024-Q2 | Increased | 205,552 | +13.9% | $5M | 0.0% | $24.35 | 31 |